Summary |
|
||||||||||||
Transgene origin |
|
||||||||||||
Transgene description |
|
||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
||||||||||||
Expression |
|
||||||||||||
Find Mice (IMSR) |
|
||||||||||||
Notes |
Transgenic founder lines F21380, F21407, and F21388 were established. The latency of disease if reflective of the level of transgene expression. Founders F21388 and F21407 express high levels of the transgene compared to founder F21380. Survival time is the shortest in founder F21407, intermediate in founder F21388, and longest in founder F21380.
|
||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/22/2024 MGI 6.24 |
|
|